US Patent Issued to Asclepix Therapeutics on Feb. 3 for "Compositions and methods for treating ocular disease" (Maryland Inventor)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,171, issued on Feb. 3, was assigned to Asclepix Therapeutics Inc. (Baltimore).

"Compositions and methods for treating ocular disease" was invented by Niranjan B. Pandey (Baltimore).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and pharmaceutical compositions for treating ocular disease are disclosed, including ocular disease involving ocular vascular permeability or ocular inflammation. In various aspects and embodiments, the invention comprises administering about 1 Mug to about 1 mg of collagen IV-derived biomimetic peptide or salt thereof to a patient by intraocular injection. Injections are provided at a frequency of from about monthly to...